Definitive Healthcare (NASDAQ:DH) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says
Definitive Healthcare (NASDAQ:DH – Get Free Report) had its price target increased by analysts at The Goldman Sachs Group from $3.00 to $3.40 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. The Goldman Sachs Group’s target price indicates a potential downside of 5.56% from […]
Definitive Healthcare (NASDAQ:DH – Get Free Report) had its price target increased by analysts at The Goldman Sachs Group from $3.00 to $3.40 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. The Goldman Sachs Group’s target price indicates a potential downside of 5.56% from […]
